Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $70,596 | 52 | 93.5% |
| Food and Beverage | $4,702 | 262 | 6.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $191.36 | 11 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $70,695 | 59 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $619.31 | 47 | $0 (2024) |
| MDD US Operations, LLC | $295.49 | 7 | $0 (2024) |
| UCB, Inc. | $263.72 | 10 | $0 (2024) |
| GENZYME CORPORATION | $240.63 | 12 | $0 (2023) |
| Biogen, Inc. | $234.17 | 16 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $203.98 | 18 | $0 (2020) |
| Acorda Therapeutics, Inc | $191.36 | 11 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $172.44 | 10 | $0 (2023) |
| Genentech USA, Inc. | $167.34 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,018 | 43 | MDD US Operations, LLC ($295.49) |
| 2023 | $440.95 | 31 | Novartis Pharmaceuticals Corporation ($197.31) |
| 2022 | $98.55 | 5 | ABBVIE INC. ($29.97) |
| 2021 | $219.24 | 9 | Janssen Pharmaceuticals, Inc ($56.87) |
| 2020 | $1,898 | 17 | PFIZER INC. ($1,522) |
| 2019 | $19,158 | 53 | PFIZER INC. ($18,460) |
| 2018 | $27,022 | 71 | PFIZER INC. ($26,203) |
| 2017 | $25,634 | 96 | PFIZER INC. ($24,483) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $34.83 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Immunology and Neurology | ||||||
| 08/30/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Neuroscience | ||||||
| 08/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neurology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: Neurology | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: Neurology | ||||||
| 06/11/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Neurology | ||||||
| 06/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: AMANTADINE | ||||||
| 06/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $37.80 | General |
| Category: Neurology | ||||||
| 05/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Neurology | ||||||
| 05/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: Neurology | ||||||
| 05/15/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: Neurology | ||||||
| 05/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: EPILEPSY | ||||||
| 05/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: AMANTADINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 204 | 227 | $56,071 | $20,565 |
| 2022 | 9 | 249 | 290 | $82,333 | $29,279 |
| 2021 | 7 | 245 | 286 | $77,816 | $29,357 |
| 2020 | 8 | 304 | 322 | $88,168 | $32,803 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 57 | 57 | $15,561 | $4,968 | 31.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 35 | 35 | $12,880 | $4,171 | 32.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 31 | 38 | $10,602 | $3,431 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 37 | $7,178 | $2,275 | 31.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,406 | $2,273 | 42.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 11 | 11 | $2,167 | $637.16 | 29.4% |
About Dr. Isaac Silverman, M.D
Dr. Isaac Silverman, M.D is a Vascular Neurology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326058108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Isaac Silverman, M.D has received a total of $75,489 in payments from pharmaceutical and medical device companies, with $1,018 received in 2024. These payments were reported across 325 transactions from 50 companies. The most common payment nature is "Consulting Fee" ($70,596).
As a Medicare-enrolled provider, Silverman has provided services to 1,002 Medicare beneficiaries, totaling 1,125 services with total Medicare billing of $112,004. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Vascular Neurology
- Location Hartford, CT
- Active Since 08/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084V0102X
- Entity Type Individual
- NPI Number 1326058108
Products in Payments
- STEGLATRO (Drug) $43,987
- KESIMPTA (Drug) $399.87
- Gocovri (Drug) $295.49
- NUPLAZID (Drug) $172.44
- RYTARY (Drug) $152.99
- COPAXONE (Drug) $152.72
- AMPYRA (Drug) $143.91
- APTIOM (Drug) $131.74
- ANDEXXA (Biological) $130.49
- Hizentra (Biological) $127.21
- NUEDEXTA (Drug) $125.08
- TYSABRI (Biological) $122.37
- AIMOVIG (Biological) $112.07
- Briviact (Drug) $107.93
- Aimovig (Biological) $105.54
- Gamunex-C (Biological) $98.99
- Vimpat (Drug) $89.77
- TROKENDI XR (Drug) $84.39
- TECFIDERA (Drug) $83.37
- AUBAGIO (Drug) $81.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular Neurology Doctors in Hartford
Kelly Matmati, M.d, M.D
Vascular Neurology — Payments: $3,010
Syed Daniyal Asad, M.d, M.D
Vascular Neurology — Payments: $228.61
Raymond Catton, Md, MD
Vascular Neurology — Payments: $190.66
Catherine Hosley, M.d, M.D
Vascular Neurology — Payments: $112.49
Dr. Robert Berland, M.d, M.D
Vascular Neurology